A randomized, parallel group, open-label, active controlled, multicenter Phase III trial of Patupilone (EP0906) versus pegylated liposomal doxorubicin (Doxil/Caelyx) in taxane/platinum refractory/resistant patients with recurrent epithelial

Project: Research

Participants

Colleges, School and Institutes

Short titleA randomized, parallel group, open-label, active controlled, multicenter Phase III trial of Patupilone (EP0906) versus pegylated liposomal doxorubicin (Doxil/Caelyx) in taxane/platinum refractory/resistant patients with recurrent epithelial
StatusFinished
Effective start/end date1/06/0731/12/11